R

Response Oncology Inc
OTC:ROIX

Watchlist Manager
Response Oncology Inc
OTC:ROIX
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 12 USD

Intrinsic Value

ROIX price has not been updated for more than 1 month. This may indicate that the stock has been delisted.
ROIX latest financial reports are more than 20 years old.
ROIX doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of ROIX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ROIX Intrinsic Value
Not Available
R
Base Case Scenario
Compare ROIX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ROIX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Response Oncology Inc

Current Assets 25.8m
Cash & Short-Term Investments 9m
Receivables 3.5m
Other Current Assets 13.4m
Non-Current Assets 358k
PP&E 260k
Other Non-Current Assets 98k
Current Liabilities 1.9m
Accounts Payable 456k
Accrued Liabilities 1.5m
Non-Current Liabilities 43.2m
Other Non-Current Liabilities 43.2m
Efficiency

Free Cash Flow Analysis
Response Oncology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Response Oncology Inc

Revenue
109.3m USD
Cost of Revenue
-85.3m USD
Gross Profit
24m USD
Operating Expenses
-25.4m USD
Operating Income
-1.4m USD
Other Expenses
-49.7m USD
Net Income
-51.1m USD
Fundamental Scores

ROIX Profitability Score
Profitability Due Diligence

Response Oncology Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Sustainable 3Y Average Gross Margin
Healthy Gross Margin
Declining Gross Margin
29/100
Profitability
Score

Response Oncology Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ROIX Solvency Score
Solvency Due Diligence

Response Oncology Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
50/100
Solvency
Score

Response Oncology Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ROIX Price Targets Summary
Response Oncology Inc

There are no price targets for ROIX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Response Oncology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ROIX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y